These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1787089)
1. Radiosynthesis and evaluation of N-(3-[18F]fluoropropyl)paroxetine as a radiotracer for in vivo labeling of serotonin uptake sites by PET. Suehiro M; Wilson AA; Scheffel U; Dannals RF; Ravert HT; Wagner HN Int J Rad Appl Instrum B; 1991; 18(7):791-6. PubMed ID: 1787089 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biodistribution of a new radiotracer for in vivo labeling of serotonin uptake sites by PET, cis-N,N-[11C]dimethyl-3-(2',4'-dichlorophenyl)-indanamine (cis-[11C]DDPI). Suehiro M; Scheffel U; Dannals RF; Wilson AA; Ravert HT; Wagner HN Int J Rad Appl Instrum B; 1992 Jul; 19(5):549-53. PubMed ID: 1399685 [TBL] [Abstract][Full Text] [Related]
3. Radiosynthesis and biodistribution of the S-[18F]fluoroethyl analog of McN5652. Suehiro M; Greenberg JH; Shiue CY; Gonzalez C; Dembowski B; Reivich M Nucl Med Biol; 1996 May; 23(4):407-12. PubMed ID: 8832694 [TBL] [Abstract][Full Text] [Related]
4. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors. Yang ZY; Perry B; Mukherjee J Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723 [TBL] [Abstract][Full Text] [Related]
5. In vivo labeling of serotonin uptake sites with [3H]paroxetine. Scheffel U; Hartig PR J Neurochem; 1989 May; 52(5):1605-12. PubMed ID: 2523469 [TBL] [Abstract][Full Text] [Related]
6. Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain. Zhang Y; Liu F; Xiao H; Yao X; Li G; Choi SR; Ploessl K; Zha Z; Zhu L; Kung HF Nucl Med Biol; 2018 Nov; 66():1-9. PubMed ID: 30096380 [TBL] [Abstract][Full Text] [Related]
7. A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. Suehiro M; Scheffel U; Dannals RF; Ravert HT; Ricaurte GA; Wagner HN J Nucl Med; 1993 Jan; 34(1):120-7. PubMed ID: 8418252 [TBL] [Abstract][Full Text] [Related]
8. In vivo evaluation of [18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a selective sigma-1 receptor radioligand for PET. Waterhouse RN; Collier TL Nucl Med Biol; 1997 Feb; 24(2):127-34. PubMed ID: 9089705 [TBL] [Abstract][Full Text] [Related]
9. Radiosynthesis of [18F]Lu29-024: a potential PET ligand for brain imaging of the serotonergic 5-HT2 receptor. Sobrio F; Amokhtari M; Gourand F; Dhilly M; Dauphin F; Barré L Bioorg Med Chem; 2000 Oct; 8(10):2511-8. PubMed ID: 11058046 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological investigations of [18F]MR18445, a 5-HT3 receptor partial agonist. Katounina T; Besret L; Dhilly M; Petit-Taboué MC; Barbelivien A; Baron JC; Dauphin F; Barré L Bioorg Med Chem; 1998 Jun; 6(6):789-95. PubMed ID: 9681144 [TBL] [Abstract][Full Text] [Related]
11. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640 [TBL] [Abstract][Full Text] [Related]
12. [11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET. Suehiro M; Scheffel U; Ravert HT; Dannals RF; Wagner HN Life Sci; 1993; 53(11):883-92. PubMed ID: 8366755 [TBL] [Abstract][Full Text] [Related]
13. Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand? Scheffel U; Ricaurte GA Brain Res; 1990 Sep; 527(1):89-95. PubMed ID: 1980843 [TBL] [Abstract][Full Text] [Related]
14. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Mukherjee J; Yang ZY; Das MK; Brown T Nucl Med Biol; 1995 Apr; 22(3):283-96. PubMed ID: 7627142 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex. Samnick S; Ametamey S; Leenders KL; Vontobel P; Quack G; Parsons CG; Neu H; Schubiger PA Nucl Med Biol; 1998 May; 25(4):323-30. PubMed ID: 9639292 [TBL] [Abstract][Full Text] [Related]
17. Automation of the radiosynthesis and purification procedures for [18F]Fluspidine preparation, a new radiotracer for clinical investigations in PET imaging of σ(1) receptors in brain. Maisonial-Besset A; Funke U; Wenzel B; Fischer S; Holl K; Wünsch B; Steinbach J; Brust P Appl Radiat Isot; 2014 Feb; 84():1-7. PubMed ID: 24291352 [TBL] [Abstract][Full Text] [Related]
18. Development of N-[3-(2',4'-dichlorophenoxy)-2-18F-fluoropropyl]-N-methylpropargylamine (18F-fluoroclorgyline) as a potential PET radiotracer for monoamine oxidase-A. Mukherjee J; Yang ZY Nucl Med Biol; 1999 Aug; 26(6):619-25. PubMed ID: 10587099 [TBL] [Abstract][Full Text] [Related]
19. New PET imaging agent for the serotonin transporter: [(18)F]ACF (2-[(2-amino-4-chloro-5-fluorophenyl)thio]-N,N-dimethyl-benzenmethanamine). Oya S; Choi SR; Coenen H; Kung HF J Med Chem; 2002 Oct; 45(21):4716-23. PubMed ID: 12361398 [TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging. Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]